Details
November 16, 2021
5:45PM - 8:00PM
Precision Medicine Oncology Symposium: From the Basics to Current Clinical Applications
Part 2
A Virtual Event
Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of genome sequencing and genomic profiling has significantly improved the diagnoses and treatment of oncologic diseases by identifying unique variants that can be targeted with gene-based targeted therapeutic approaches, including immunotherapies.
The series is designed to provide oncology clinicians and researchers foundational information on the latest technologies available for data acquisition, diagnosis, and decision-making for oncologic diseases.
Part 2 Topics Include
- Liquid Biopsy: Advantages and Limitations
- Geoff Oxnard, MD
Foundation Medicine
- Germline Mutations and Hereditary Cancers
- Elena Stoffel, MD, MPH
University of Michigan
- Tumor Board Case Session
- Breast
- Lynn Henry, MD, PhD
University of Michigan
- GU
- Clara Hwang, MD
Henry Ford
Continuing Education
No CME credits will be awarded for this session.
Be sure to also register for Part 1 of this series on November 4!
Printer-Friendly Version
Add to Calendar
aCLuDhaqizCaPxAftmqF167204
11/16/2021 05:45 PM
11/16/2021 08:00 PM
false
Precision Medicine Oncology Symposium: From the Basics to Current Clinical Applications
Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of genome sequencing and genomic profiling has significantly improved the diagnoses and treatment of oncologic diseases by identifying unique variants that can be targeted with gene-based targeted therapeutic approaches, including immunotherapies.
The series is designed to provide oncology clinicians and researchers foundational information on the latest technologies available for data acquisition, diagnosis, and decision-making for oncologic diseases.
Part 2 Topics Include
Liquid Biopsy: Advantages and Limitations
Geoff Oxnard, MDFoundation Medicine
Germline Mutations and Hereditary Cancers
Elena Stoffel, MD, MPHUniversity of Michigan
Tumor Board Case Session
Breast
Lynn Henry, MD, PhDUniversity of Michigan
GU
Clara Hwang, MDHenry Ford
Continuing EducationNo CME credits will be awarded for this session.
Click Here to Register Today!
Be sure to also register for Part 1 of this series on November 4!
A Virtual Event